Literature DB >> 21961982

MR imaging-guided cryoablation for the treatment of benign prostatic hyperplasia.

Pejman Ghanouni1, Harcharan Gill, Elena Kaye, Kim Butts Pauly, Bruce Daniel.   

Abstract

A patient with benign prostatic hyperplasia presented with chronic lower urinary tract symptoms despite prior surgery and continued medical therapy. Using a magnetic resonance imaging-guided transperineal approach, two cryoprobes were placed into the transition zone of the prostate gland, and two cryoablation freeze-thaw cycles were performed. At 10 weeks after treatment, the frequency of nocturia had decreased from once every 1.5 hours to once per night, urinary peak flow rates had increased from 5.1 mL/s to 10.3 mL/s, and postvoid residual urinary bladder volume had decreased from 187 mL to 58 mL. Improved flow rates and symptoms remained stable 16 weeks after treatment.
Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21961982      PMCID: PMC3185301          DOI: 10.1016/j.jvir.2011.08.010

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  15 in total

Review 1.  Update on minimally invasive therapies for benign prostatic hyperplasia.

Authors:  George A Turini; Gyan Pareek
Journal:  Med Health R I       Date:  2009-10

2.  Does transurethral thermotherapy induce a long-term alpha blockade? An immunohistochemical study.

Authors:  M Perachino; W Bozzo; P Puppo; A Vitali; S Ardoino; M A Ferro
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

Review 3.  Primary and salvage cryotherapy for prostate cancer.

Authors:  David S Finley; Frederic Pouliot; David C Miller; Arie S Belldegrun
Journal:  Urol Clin North Am       Date:  2010-02       Impact factor: 2.241

4.  Design considerations for a novel MRI compatible manipulator for prostate cryoablation.

Authors:  S Abdelaziz; L Esteveny; P Renaud; B Bayle; L Barbé; M De Mathelin; A Gangi
Journal:  Int J Comput Assist Radiol Surg       Date:  2011-04-12       Impact factor: 2.924

5.  PSA elevation during prostate cryosurgery and subsequent decline.

Authors:  Dan Leibovici; Amnon Zisman; Arie Lindner; Kobi Stav; Yoram I Siegel
Journal:  Urol Oncol       Date:  2005 Jan-Feb       Impact factor: 3.498

6.  Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms.

Authors:  G S Steele; M P Sullivan; D J Sleep; S V Yalla
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

Review 7.  Established medical therapy for benign prostatic hyperplasia.

Authors:  Gregory B Auffenberg; Brian T Helfand; Kevin T McVary
Journal:  Urol Clin North Am       Date:  2009-11       Impact factor: 2.241

8.  MR imaging-guided percutaneous cryoablation of the prostate in an animal model: in vivo imaging of cryoablation-induced tissue necrosis with immediate histopathologic correlation.

Authors:  Maurice A A J van den Bosch; Sonal Josan; Donna M Bouley; Jin Chen; Harcharan Gill; Viola Rieke; Kim Butts-Pauly; Bruce L Daniel
Journal:  J Vasc Interv Radiol       Date:  2008-12-16       Impact factor: 3.464

Review 9.  Nonablative minimally invasive thermal therapies in the treatment of symptomatic benign prostatic hyperplasia.

Authors:  Franck C H d'Ancona
Journal:  Curr Opin Urol       Date:  2008-01       Impact factor: 2.309

10.  [Cryosurgical ablation for aged patients with severe benign prostate hyperplasia: a report of 21 cases].

Authors:  An-xi Wang; Dong Wang; Wei Tong
Journal:  Zhonghua Nan Ke Xue       Date:  2007-05
View more
  2 in total

1.  Applicators for magnetic resonance-guided ultrasonic ablation of benign prostatic hyperplasia.

Authors:  Graham Sommer; Kim Butts Pauly; Andrew Holbrook; Juan Plata; Bruce Daniel; Donna Bouley; Harcharan Gill; Punit Prakash; Vasant Salgaonkar; Peter Jones; Chris Diederich
Journal:  Invest Radiol       Date:  2013-06       Impact factor: 6.016

2.  Computerized Planning of Prostate Cryosurgery and Shape Considerations.

Authors:  Purva Joshi; Anjali Sehrawat; Yoed Rabin
Journal:  Technol Cancer Res Treat       Date:  2017-07-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.